Human herpesvirus 6 and the nervous system

Handbook of Clinical Neurology

Volumn 123, Issue , 2014, Pages 327-355

  Hill, Joshua A ^a   Venna, Nagagopal ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Central nervous system; Encephalitis; HHV 6; Human herpesvirus 6

Indexed keywords

ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; ENCEPHALITIS; EXANTHEMA SUBITUM; HHV-6; HUMAN; HUMAN HERPESVIRUS 6; PATHOGENICITY; PATHOLOGY; ULTRASTRUCTURE; VIROLOGY;

CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; HHV-6; HUMAN HERPESVIRUS 6;

BRAIN; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; HERPESVIRUS 6, HUMAN; HUMANS; ROSEOLOVIRUS INFECTIONS;

EID: 84904008330     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53488-0.00016-X     Document Type: Chapter

References (317)

1. Ablashi D.V., Eastman H.B., Owen C.B., et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000, 16:179-191.
2. Agut H., Aubin J.T., Huraux J.M. Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro. J Infect Dis 1991, 163:1382-1383.
3. Ahlqvist J., Fotheringham J., Akhyani N., et al. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J Neurovirol 2005, 11:384-394.
4. Ahram M., El-Omar A., Baho Y., et al. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol Scand 2009, 120:430-435.
5. Akhyani N., Berti R., Brennan M.B., et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000, 182:1321-1325.
6. Akhyani N., Fotheringham J., Yao K., et al. Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells. J Neurovirol 2006, 12:284-293.
7. Alvarez-Lafuente R., Martin-Estefania C., de las Heras V., et al. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand 2002, 105:95-99.
8. Alvarez-Lafuente R., Martin-Estefania C., de Las Heras V., et al. Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch Neurol 2002, 59:929-933.
9. Alvarez-Lafuente R., Las Heras De V., Bartolome M., et al. Human herpesvirus 6 and multiple sclerosis: A one-year follow-up study. Brain Pathol 2006, 16:20-27.
10. Alvarez-Lafuente R., Garcia-Montojo M., De las Heras V., et al. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. J Clin Virol 2006, 37(Suppl 1):S24-S26.
11. Alvarez-Lafuente R., de las Heras V., Garcia-Montojo M., et al. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive. Mult Scler 2007, 13:578-583.
12. Alvarez-Lafuente R., Garcia-Montojo M., De Las Heras V., et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler 2008, 14:595-601.
13. Ansari A., Li S.B., Abzug M.J., et al. Human herpesvirus-6 (HHV-6) is an uncommon cause of central nervous system (CNS) infection in children. Pediatr Res 2002, 51:1620.
14. Arbuckle J.H., Medveczky P.G. The molecular biology of human herpesvirus-6 latency and telomere integration. Microbes Infect 2011, 13:731-741.
15. Asano Y., Yoshikawa T., Suga S., et al. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990, 335:862-863.
16. Asano Y., Yoshikawa T., Suga S., et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994, 93:104-108.
17. Astriti M., Zeller V., Boutolleau D., et al. Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir. J Infect 2006, 52:237-242.
18. Babbe H., Roers A., Waisman A., et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393-404.
19. Baldwin K. Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report. J Neurovirol 2011, 17:193-195.
20. Barone S.R., Kaplan M.H., Krilov L.R. Human herpesvirus-6 infection in children with first febrile seizures. J Pediatr 1995, 127:95-97.
21. Basinski J.R., Alfano C.M., Katon W.J., et al. Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biol Blood Marrow Transplant 2010, 16:824-831.
22. Bech E., Lycke J., Gadeberg P., et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 2002, 58:31-36.
23. Berti R., Brennan M.B., Soldan S.S., et al. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 2002, 8:250-256.
24. Bethge W., Beck R., Jahn G., et al. Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 1999, 24:1245-1248.
25. Betts B.C., Young J.A., Ustun C., et al. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?. Biol Blood Marrow Transplant 2011, 17:1562-1568.
26. Biberfeld P., Kramarsky B., Salahuddin S.Z., et al. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. J Natl Cancer Inst 1987, 79:933-941.
27. Birnbaum T., Padovan C.S., Sporer B., et al. Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis 2005, 40:887-889.
28. Blumberg B.M., Mock D.J., Powers J.M., et al. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol 2000, 16:159-178.
29. Blumberg B.M., Mock D.J., Powers J.M., et al. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol 2000, 16:159-178.
30. Boeckh M., Nichols W.G. Immunosuppressive effects of beta-herpesviruses. Herpes 2003, 10:12-16.
31. Bollen A.E., Wartan A.N., Krikke A.P., et al. Amnestic syndrome after lung transplantation by human herpes virus-6 encephalitis. J Neurol 2001, 248:619-620.
32. Bommer M., Pauls S., Greiner J. Challenging complications of treatment - human herpes virus 6 encephalitis and pneumonitis in a patient undergoing autologous stem cell transplantation for relapsed Hodgkin's disease: a case report. Virol J 2009, 6:111.
33. Bonnafous P., Bogaert S., Godet AN., et al. HDP-CDV as an alternative for treatment of human herpesvirus-6 infections. J Clin Virol 2013, 56:175-176.
34. Bonnafous P., Boutolleau D., Naesens L., et al. Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection. Antiviral Res 2008, 77:237-240.
35. Bossolasco S., Marenzi R., Dahl H., et al. Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance. J Neurol Neurosurg Psychiatry 1999, 67:789-792.
36. Boutolleau D., Cointe D., Gautheret-Dejean A., et al. No evidence for a major risk of roseolovirus vertical transmission during pregnancy. Clin Infect Dis 2003, 36:1634-1635.
37. Boutolleau D., Duros C., Bonnafous P., et al. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 2006, 35:257-263.
38. Braun D.K., Pellett P.E., Hanson C.A. Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive, T cell chronic lymphoproliferative disease. J Infect Dis 1995, 171:1351-1355.
39. Braun D.K., Dominguez G., Pellett P.E. Human herpesvirus 6. Clin Microbiol Rev 1997, 10:521-567.
40. Broccolo F., Iuliano R., Careddu A.M., et al. Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Acta Virol 2000, 44:137-143.
41. Brown F., Banken L., Saywell K., et al. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers. Clin Pharmacokinet 1999, 37:167-176.
42. Buchbinder S., Elmaagacli A.H., Schaefer U.W., et al. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000, 26:639-644.
43. Buchwald D., Cheney P.R., Peterson D.L., et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992, 116:103-113.
44. Burns W.H., Sandford G.R. Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis 1990, 162:634-637.
45. Carnero S.R., Martinez-Vazquez C., Alvarellos C.P., et al. Lack of human herpesvirus type 6 DNA in CSF by nested PCR among patients with multiple sclerosis. Rev Clin Esp 2002, 202:588-591.
46. Caserta M.T., Hall C.B., Schnabel K., et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994, 170:1586-1589.
47. Cermelli C., Jacobson S. Viruses and multiple sclerosis. Viral Immunol 2000, 13:255-267.
48. Cermelli C., Berti R., Soldan S.S., et al. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 2003, 187:1377-1387.
49. Challoner P.B., Smith K.T., Parker J.D., et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995, 92:7440-7444.
50. Chan P.K., Ng H.K., Cheng A.F. Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours. J Clin Pathol 1999, 52:620-623.
51. Chan P.K., Chan M.Y., Li W.W., et al. Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors. J Clin Pathol 2001, 54:48-53.
52. Chan P.K., Ng H.K., Hui M., et al. Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J Med Virol 2001, 64:42-46.
53. Chang Y.L., Parker M.E., Nuovo G., et al. Human herpesvirus 6-related fulminant myocarditis and hepatitis in an immunocompetent adult with fatal outcome. Hum Pathol 2009, 40:740-745.
54. Chapenko S., Millers A., Nora Z., et al. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 2003, 69:111-117.
55. Chen M., Wang H., Woodworth C.D., et al. Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma. Am J Pathol 1994, 145:1509-1516.
56. Chevallier P., Hebia-Fellah I., Planche L., et al. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant 2010, 45:1204-1211.
57. Cinque P., Vago L., Dahl H., et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996, 10:951-958.
58. Cirone M., Cuomo L., Zompetta C., et al. Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens. J Med Virol 2002, 68:268-272.
59. Coen D.M., Schaffer P.A. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov 2003, 2:278-288.
60. Collot S., Petit B., Bordessoule D., et al. Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva. J Clin Microbiol 2002, 40:2445-2451.
61. Cone R.W., Hackman R.C., Huang M.L., et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993, 329:156-161.
62. Cone R.W., Huang M.L., Ashley R., et al. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 1994, 32:2633.
63. Corti M., Villafane F., Trione N., et al. Primary central nervous system lymphomas in AIDS patients. Enferm Infecc Microbiol Clin 2004, 22:332-336.
64. Crawford J.R., Kadom N., Santi M.R., et al. Human herpesvirus 6 rhombencephalitis in immunocompetent children. J Child Neurol 2007, 22:1260-1268.
65. Crawford J.R., Chang T., Lavenstein B.L., et al. Acute and chronic magnetic resonance imaging of human herpesvirus-6 associated encephalitis. J Pediatr Neurol 2009, 7:367-373.
66. Crawford J.R., Santi M.R., Cornelison R., et al. Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors. J Neurooncol 2009, 95:49-60.
67. Crawford J.R., Santi M.R., Thorarinsdottir H.K., et al. Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol 2009, 46:37-42.
68. Cuomo L., Trivedi P., Cardillo M.R., et al. Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol 2001, 63:45-51.
69. Daibata M., Hatakeyama N., Kamioka M., et al. Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma. Am J Hematol 2001, 67:200-205.
70. Danbolt N.C. Glutamate uptake. Prog Neurobiol 2001, 65:1-105.
71. De Bolle L., Andrei G., Snoeck R., et al. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochem Pharmacol 2004, 67:325-336.
72. De Bolle L., Hatse S., Verbeken E., et al. Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle. FEBS Lett 2004, 560:25-29.
73. De Bolle L., Naesens L., De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005, 18:217-245.
74. De Clercq E., Naesens L., De Bolle L., et al. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001, 11:381-395.
75. Denes E., Magy L., Pradeau K., et al. Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg Infect Dis 2004, 10:729-731.
76. Derfuss T., Hohlfeld R., Meinl E. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol 2005, 252:968-971.
77. Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004, 11(Suppl 2):105A-111A.
78. Dewhurst S., McIntyre K., Schnabel K., et al. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol 1993, 31:416-418.
79. Dietrich J., Blumberg B.M., Roshal M., et al. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci 2004, 24:4875-4883.
80. Dockrell D.H., Mendez J.C., Jones M., et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999, 67:399-403.
81. Dominguez G., Dambaugh T.R., Stamey F.R., et al. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 1999, 73:8040-8052.
82. Donati D., Akhyani N., Fogdell-Hahn A., et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 2003, 61:1405-1411.
83. Drobyski W.R., Eberle M., Majewski D., et al. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol 1993, 31:1515-1520.
84. Drobyski W.R., Knox K.K., Majewski D., et al. Brief report: Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994, 330:1356-1360.
85. Enbom M., Wang F.Z., Fredrikson S., et al. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol 1999, 6:545-549.
86. Evans A.S. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 1976, 49:175-195.
87. Fann J.R., Alfano C.M., Roth-Roemer S., et al. Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol 2007, 25:1223-1231.
88. Fantry L.E., Cleghorn F.R. HHV-6 infection in patients with HIV-1 infection and disease. AIDS Read 1999, 9(198-203):221.
89. Flamand L., Gosselin J., Stefanescu I., et al. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995, 85:1263-1271.
90. Flamand L., Komaroff A.L., Arbuckle J.H., et al. Review, part 1: human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J Med Virol 2010, 82:1560-1568.
91. Fotheringham J., Akhyani N., Vortmeyer A., et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007, 195:450-454.
92. Fotheringham J., Donati D., Akhyani N., et al. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 2007, 4:e180.
93. Fox J.D., Briggs M., Ward P.A., et al. Human herpesvirus 6 in salivary glands. Lancet 1990, 336:590-593.
94. Friedman J.E., Lyons M.J., Cu G., et al. The association of the human herpesvirus-6 and MS. Mult Scler 1999, 5:355-362.
95. Fujimaki K., Mori T., Kida A., et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006, 84:432-437.
96. Fukae S., Ashizawa N., Morikawa S., et al. A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med 2000, 39:632-636.
97. Fukuda K., Straus S.E., Hickie I., et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994, 121:953-959.
98. Garcia-Montojo M., Heras V.D.L., Bartolome M., et al. Interferon beta treatment: bioavailability and antiviral activity in multiple sclerosis patients. J Neurovirol 2007, 13:504-512.
99. Gardell J.L., Dazin P., Islar J., et al. Apoptotic effects of human herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity. J Clin Virol 2006, 37(Suppl 1):S11-S16.
100. Gautheret-Dejean A., Manichanh C., Thien-Ah-Koon F., et al. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 2002, 100:27-35.
101. Gewurz B.E., Marty F.M., Baden L.R., et al. Human herpesvirus 6 encephalitis. Curr Infect Dis Rep 2008, 10:292-299.
102. Goodman A.D., Mock D.J., Powers J.M., et al. Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 2003, 187:1365-1376.
103. Gorniak R.J.T., Young G.S., Wiese D.E., et al. MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation. AJNR Am J Neuroradiol 2006, 27:887-891.
104. Griffiths P.D., Ait-Khaled M., Bearcroft C.P., et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999, 59:496-501.
105. Gulley M.L. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001, 3:1-10.
106. Gutierrez J., Vergara M.J., Guerrero M., et al. Multiple sclerosis and human herpesvirus 6. Infection 2002, 30:145-149.
107. Hall C.B., Long C.E., Schnabel K.C., et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994, 331:432-438.
108. Hall C.B., Caserta M.T., Schnabel K.C., et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998, 26:132-137.
109. Hashimoto H., Maruyama H., Fujimoto K., et al. Hematologic findings associated with thrombocytopenia during the acute phase of exanthem subitum confirmed by primary human herpesvirus-6 infection. J Pediatr Hematol Oncol 2002, 24:211-214.
110. Hennus M.P., Van Montfrans J.M., Van Vught A.J., et al. Life-threatening human herpes virus-6 infection in early childhood: presenting symptom of a primary immunodeficiency?. Pediatr Crit Care Med 2009, 10:e16-e18.
111. Hickie I., Davenport T., Wakefield D., et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006, 333:575.
112. Higashi K., Asada H., Kurata T., et al. Presence of antibody to human herpesvirus 6 in monkeys. J Gen Virol 1989, 70:3171-3176.
113. Hill A.E., Hicks E.M., Coyle P.V. Human herpes virus 6 and central nervous system complications. Dev Med Child Neurol 1994, 36(7):651-652.
114. Hill J.A., Koo S., Guzman Suarez B.B., et al. Cord-blood hematopoietic stem cell transplantation confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant 2012, 18:1638-1648.
115. Hill JA, Myerson D, Sedlak RH et al. (2014). Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature. Transpl Infect Dis (in press).
116. Hong J., Tejada-Simon M.V., Rivera V.M., et al. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler 2002, 8:237-242.
117. Horvat R.T., Parmely M.J., Chandran B. Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J Infect Dis 1993, 167:1274-1280.
118. Hoshino K., Nishi T., Adachi H., et al. Human herpesvirus-6 infection in renal allografts: retrospective immunohistochemical study in Japanese recipients. Transpl Int 1995, 8:169-173.
119. Hukin J., Farrell J., MacWilliam L.M., et al. Case-control study of primary human herpesvirus 6 infection in children with febrile seizures. Pediatrics 1998, 101(2).
120. Humar A., Malkan G., Moussa G., et al. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000, 181:1450-1453.
121. Ichimi R., Jin-no T., Ito M. Induction of apoptosis in cord blood lymphocytes by HHV-6. J Med Virol 1999, 58:63-68.
122. Ihira M., Yoshikawa T., Suzuki K., et al. Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR. Microbiol Immunol 2002, 46:701-705.
123. Ihira M., Yoshikawa T., Enomoto Y., et al. Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification. J Clin Microbiol 2004, 42:140-145.
124. Inoue Y., Yasukawa M., Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J Virol 1997, 71:3751-3759.
125. Isaacson E., Glaser C.A., Forghani B., et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 2005, 40:890-893.
126. Isegawa Y., Mukai T., Nakano K., et al. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 1999, 73:8053-8063.
127. Isegawa Y., Hara J., Amo K., et al. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. J Clin Virol 2009, 44:15-19.
128. Ishiguro N., Yamada S., Takahashi T., et al. Meningo-encephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 1990, 79:987-989.
129. Ishikawa K., Hasegawa K., Naritomi T., et al. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol 2002, 37:523-530.
130. Ishiyama K., Katagiri T., Hoshino T., et al. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT. Bone Marrow Transplant 2011, 46:863-869.
131. Ito M., Baker J.V., Mock D.J., et al. Human herpesvirus 6-meningoencephalitis in an HIV patient with progressive multifocal leukoencephalopathy. Acta Neuropathol 2000, 100:337-341.
132. Izikson L., Klein R.S., Charo I.F., et al. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 2000, 192:1075-1080.
133. Jacobs F., Knoop C., Brancart F., et al. Human herpesvirus-6 infection after lung and heart-lung transplantation: a prospective longitudinal study. Transplantation 2003, 75:1996-2001.
134. Johnston R.E., Geretti A.M., Prentice H.G., et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999, 105:1041-1043.
135. Jones C.M.V., Dunn H.G., Thomas E.E., et al. Acute encephalopathy and status epilepticus associated with human herpes virus 6 infection. Dev Med Child Neurol 1994, 36:646-650.
136. Kato Z., Kozawa R., Teramoto T., et al. Acute cerebellitis in primary human herpesvirus-6 infection. Eur J Pediatr 2003, 162:801-803.
137. Kern E.R., Kushner N.L., Hartline C.B., et al. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication. Antimicrob Agents Chemother 2005, 49:1039-1045.
138. Kim J.S., Lee K.S., Park J.H., et al. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur Neurol 2000, 43:170-173.
139. Kimura S., Nezu A. Neuroradiologic findings of brain lesions related to exanthema subitum. Pediatr Neurol 1998, 19:343-346.
140. Kitsos D.K., Tsiodras S., Poulios A., et al. Evaluation of immunological and clinical parameters in patients with primary progressive and secondary progressive multiple sclerosis: A case control study of 60 patients. J Neurol 2011, 258:S200.
141. Knox K.K., Carrigan D.R. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:69-73.
142. Knox K.K., Carrigan D.R. High prevalence of active human herpesvirus-6 variant A infection in central nervous system and lymphoid tissues of patients with multiple sclerosis. Ann Neurol 2000, 48:132.
143. Knox K.K., Harrington D.P., Carrigan D.R. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995, 45:288-292.
144. Koch R. An address on bacteriological research. Br Med J 1890, 2:380-383.
145. Koelle D.M., Barcy S., Huang M.L., et al. Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome. Clin Infect Dis 2002, 35:518-525.
146. Kogelnik A.M., Loomis K., Hoegh-Petersen M., et al. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol 2006, 37(Suppl 1):S33-S38.
147. Komaroff A.L. Is human herpesvirus-6 a trigger for chronic fatigue syndrome?. J Clin Virol 2006, 37(Suppl 1):S39-S46.
148. Komaroff A.L., Fagioli L.R., Doolittle T.H., et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996, 101:281-290.
149. Kondo K., Kondo T., Okuno T., et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991, 72:1401-1408.
150. Kondo K., Nagafuji H., Hata A., et al. Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993, 167:1197-1200.
151. Kong H., Baerbig Q., Duncan L., et al. Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death. J Neurovirol 2003, 9:539-550.
152. Krueger G.R., Huetter M.L., Rojo J., et al. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's diseases and their relation to proliferation and apoptosis. Anticancer Res 2001, 21:2155-2161.
153. Kuusisto H., Hyoty H., Kares S., et al. Human herpes virus 6 and multiple sclerosis: a Finnish twin study. Mult Scler 2008, 14:54-58.
154. Lautenschlager I., Hockerstedt K., Linnavuori K., et al. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998, 26:702-707.
155. Lehto J.T., Halme M., Tukiainen P., et al. Human herpesvirus-6 and -7 after lung and heart-lung transplantation. J Heart Lung Transplant 2007, 26:41-47.
156. Leong H.N., Tuke P.W., Tedder R.S., et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 2007, 79:45-51.
157. Li J.M., Lei D., Peng F., et al. Detection of human herpes virus 6B in patients with mesial temporal lobe epilepsy in West China and the possible association with elevated NF-(kappa)B expression. Epilepsy Res 2011, 94:1-9.
158. Liedtke W., Malessa R., Faustmann P.M., et al. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995, 1:253-258.
159. Ljungman P., Wang F.Z., Clark D.A., et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000, 111:774-781.
160. Loginov R., Mannonen L., Karlsson T., et al. Development of a quantitative real-time HHV-6-PCR: Comparison of the results to qualitative nullin-housenull PCR and commercial quantitative PCR Argene CMV, HHV6,7,8 R-geneTM kit. Clin Microbiol Infect 2009, 15:S119.
161. Lou J., Wu Y., Cai M., et al. Subtype-specific, probe-based, real-time PCR for detection and typing of human herpesvirus-6 encephalitis from pediatric patients under the age of 2 years. Diagn Microbiol Infect Dis 2011, 70:223-229.
162. Luppi M., Barozzi P., Maiorana A., et al. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994, 169:943-944.
163. Luppi M., Barozzi P., Maiorana A., et al. Human herpesvirus-6 - a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J Med Virol 1995, 47:105-111.
164. Luppi M., Barozzi P., Garber R., et al. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol 1998, 153:815-823.
165. Luppi M., Barozzi P., Morris C., et al. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol 1999, 73:754-759.
166. Lusso P. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 2006, 37(Suppl 1):S4-S10.
167. Luttichau H.R., Clark-Lewis I., Jensen P.O., et al. A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J Biol Chem 2003, 278:10928-10933.
168. Lycke J., Svennerholm B., Hjelmquist E., et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol 1996, 243:214-224.
169. Madeley C.R. "Is it the cause?" - Robert Koch and viruses in the 21st century. J Clin Virol 2008, 43:9-12.
170. Maeda T., Okuno T., Hayashi K., et al. Outcomes of infants whose mothers are positive for human herpesvirus-6 DNA within the genital tract in early gestation. Acta Paediatr Jpn 1997, 39:653-657.
171. Mameli G., Astone V., Arru G., et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol 2007, 88:264-274.
172. Manichanh C., Grenot P., Gautheret-Dejean A., et al. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry 2000, 40:135-140.
173. Manichanh C., Olivier-Aubron C., Lagarde J.P., et al. Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J Gen Virol 2001, 82:2767-2776.
174. Marty F.M., Winston D.J., Rowley S.D., et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 2013, 369:1227-1236.
175. Mayne M., Krishnan J., Metz L., et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol 1998, 44:391-394.
176. McCullers J.A., Lakeman F.D., Whitley R.J. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995, 21:571-576.
177. McGavin J.K., Goa K.L. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 2001, 61:1153-1183.
178. Mendel I., de Matteis M., Bertin C., et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 1995, 14:993-997.
179. Millichap J.G., Millichap J.J. Role of viral infections in the etiology of febrile seizures. Pediatr Neurol 2006, 35:165-172.
180. Mirandola P., Stefan A., Brambilla E., et al. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999, 53:1367-1368.
181. Miyagishi R., Niino M., Fukazawa T., et al. C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol 2003, 145:135-138.
182. Mock D.J., Powers J.M., Goodman A.D., et al. Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. J Neurovirol 1999, 5:363-373.
183. Montejo M., Fernandez J.R., Testillano M., et al. Encephalitis caused by human herpesvirus-6 in a liver transplant recipient. Eur Neurol 2002, 48:234-235.
184. Mookerjee B.P., Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997, 20:905-906.
185. Moore F.G.A., Wolfson C. Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand 2002, 106:63-83.
186. Mori Y., Yang X., Akkapaiboon P., et al. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 2003, 77:4992-4999.
187. Mori T., Mihara A., Yamazaki R., et al. Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation. Scand J Infect Dis 2007, 39:276-278.
188. Mori Y., Miyamoto T., Nagafuji K., et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant 2010, 16:1596-1602.
189. Mukai T., Yamamoto T., Kondo T., et al. Molecular epidemiological studies of human herpesvirus 6 in families. J Med Virol 1994, 42:224-227.
190. Muta T., Fukuda T., Harada M. Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant 2009, 43:583-585.
191. Nagasawa T., Kimura I., Abe Y., et al. HHV-6 encephalopathy with cluster of convulsions during eruptive stage. Pediatr Neurol 2007, 36:61-63.
192. Nakayama T., Okada F., Ando Y., et al. A case of pneumonitis and encephalitis associated with human herpesvirus 6 (HHV-6) infection after bone marrow transplantation. Br J Radiol 2010, 83:e255-e258.
193. Neves A.M., Thompson G., Carvalheira J., et al. Detection and quantitative analysis of human herpesvirus in pilocytic astrocytoma. Brain Res 2008, 1221:108-114.
194. Nicolson G.L., Gan R., Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS 2003, 111:557-566.
195. Nigro G., Luzi G., Krzysztofiak A., et al. Detection of IgM antibodies to human herpesvirus 6 in Romanian children with nonprogressive human immunodeficiency virus disease. Pediatr Infect Dis J 1995, 14:891-894.
196. Nishimaki K., Okada S., Miyamura K., et al. The possible involvement of human herpesvirus type 6 in obliterative bronchiolitis after bone marrow transplantation. Bone Marrow Transplant 2003, 32:1103-1105.
197. Noguchi T., Mihara F., Yoshiura T., et al. MR imaging of human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation in adults. AJNR Am J Neuroradiol 2006, 27:2191-2195.
198. Norton R.A., Caserta M.T., Hall C.B., et al. Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol 1999, 37:3672-3675.
199. Noseworthy J.H., Lucchinetti C., Rodriguez M., et al. Multiple sclerosis. N Engl J Med 2000, 343:938-952.
200. Ogata M., Kadota J. Human herpesvirus-6 infections and infection-preventative measures in transplant recipients. Future Virol 2008, 3:567-578.
201. Ogata M., Kikuchi H., Satou T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006, 193:68-79.
202. Ogata M., Satou T., Kawano R., et al. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2010, 45:129-136.
203. Oki J., Yoshida H., Tokumitsu A., et al. Serial neuroimages of acute necrotizing encephalopathy associated with human herpesvirus 6 infection. Brain Dev 1995, 17:356-359.
204. Okuno T., Takahashi K., Balachandra K., et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989, 27:651-653.
205. Opsahl M.L., Kennedy P.G.E. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005, 128:516-527.
206. Opsahl M.L., Kennedy P.G. Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J Neurol Sci 2006, 240:37-44.
207. Ortega-Hernandez O., Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence. Ann N Y Acad Sci 2009, 1173:600-609.
208. Osiowy C., Prud'homme I., Monette M., et al. Detection of human herpesvirus 6 DNA in serum by a microplate PCR-hybridization assay. J Clin Microbiol 1998, 36:68-72.
209. Paterson D.L., Singh N., Gayowski T., et al. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. Liver Transpl Surg 1999, 5:454-455.
210. Patnaik M., Peter J.B. Intrathecal synthesis of antibodies to human herpesvirus 6 early antigen in patients with meningitis/encephalitis. Clin Infect Dis 1995, 21:715-716.
211. Patnaik M., Komaroff A.L., Conley E., et al. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995, 172:1364-1367.
212. Paulus W., Jellinger K., Hallas C., et al. Human herpesvirus-6 and Epstein-Barr-virus genome in primary cerebral lymphomas. Neurology 1993, 43:1591-1593.
213. Pellett P.E., Ablashi D.V., Ambros P.F., et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2011, 22:144-155.
214. Portolani M., Cermelli C., Meacci M., et al. Primary infection by HHV-6 variant B associated with a fatal case of hemophagocytic syndrome. New Microbiol 1997, 20:7-11.
215. Portolani M., Pecorari M., Gennari W., et al. Case report: primary infection by human herpesvirus 6 variant a with the onset of myelitis. Herpes 2006, 13:72-74.
216. Pot C., Burkhard P.R., Villard J., et al. Human herpesvirus-6 variant A encephalomyelitis. Neurology 2008, 70:974-976.
217. Proper E.A., Hoogland G., Kappen S.M., et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 2002, 125:32-43.
218. Provenzale J.M., vanLandingham K.E., Lewis D.V., et al. Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging. Radiology 2008, 249:955-963.
219. Provenzale J.M., van Landingham K., White L.E. Clinical and imaging findings suggesting human herpesvirus 6 encephalitis. Pediatr Neurol 2010, 42:32-39.
220. Quereda C., Corral I., Laguna F., et al. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol 2000, 38:3061-3067.
221. Rapaport D., Engelhard D., Tagger G., et al. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002, 4:10-16.
222. Reardon J.E., Spector T. Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J Biol Chem 1989, 264:7405-7411.
223. Reeves W.C., Stamey F.R., Black J.B., et al. Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study. Clin Infect Dis 2000, 31:48-52.
224. Reymen D., Naesens L., Balzarini J., et al. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 1995, 28:343-357.
225. Rieux C., Gautheret-Dejean A., Challine-Lehmann D., et al. Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation. Transplantation 1998, 65:1408-1411.
226. Rogers J., Rohal S., Carrigan D.R., et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000, 69:2566-2573.
227. Rogers J., Rohal S., Carrigan D.R., et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000, 69:2566-2573.
228. Rojo J., Ferrer Argote V.E., Klueppelberg U., et al. Semi-quantitative in situ hybridization and immunohistology for antigen expression of human herpesvirus-6 in various lymphoproliferative diseases. In Vivo 1994, 8:517-526.
229. Rossi C., Delforge M.L., Jacobs F., et al. Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation 2001, 71:288-292.
230. Rotola A., Cassai E., Tola M.R., et al. Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1999, 67:529-531.
231. Saddawi-Konefka R., Crawford J.R. Chronic viral infection and primary central nervous system malignancy. J Neuroimmune Pharmacol 2010, 5:387-403.
232. Safronetz D., Petric M., Tellier R., et al. Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase. J Med Virol 2003, 71:434-439.
233. Saijo M., Saijo H., Yamamoto M., et al. Thrombocytopenic purpura associated with primary human herpesvirus 6 infection. Pediatr Infect Dis J 1995, 14:405.
234. Salahuddin S.Z., Ablashi D.V., Markham P.D., et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986, 234:596-601.
235. Sashihara J., Tanaka-Taya K., Tanaka S., et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002, 100:2005-2011.
236. Secchiero P., Carrigan D.R., Asano Y., et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995, 171:273-280.
237. Seeley W.W., Marty F.M., Holmes T.M., et al. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6. Neurology 2007, 69:156-165.
238. Sever J.L., Rakusan T.A., Ellaurie M., et al. Coinfection with herpesviruses in young children of HIV-infected women. Pediatr AIDS HIV Infect 1995, 6:75-82.
239. Singh N., Carrigan D.R., Gayowski T., et al. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997, 64:674-678.
240. Sloots T.P., Mackay I.M., Carroll P. Meningoencephalitis in an adult with human herpesvirus-6 infection. Med J Aust 1993, 159:838.
241. Solbrig M.V., Hasso A.N., Jay C.A. CNS viruses - Diagnostic approach. Neuroimaging Clin N Am 2008, 18:1-18.
242. Soldan S.S., Berti R., Salem N., et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997, 3:1394-1397.
243. Soldan S.S., Leist T.P., Juhng K.N., et al. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000, 47:306-313.
244. Soldan S.S., Fogdell-Hahn A., Brennan M.B., et al. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 2001, 50:486-493.
245. Spira T.J., Bozeman L.H., Sanderlin K.C., et al. Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis 1990, 161:567-570.
246. Strayer D.R., Carter W.A., Brodsky I., et al. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. Clin Infect Dis 1994, 18(Suppl 1):S88-S95.
247. Suga S., Yoshikawa T., Asano Y., et al. Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications. Ann Neurol 1993, 33:597-603.
248. Suga S., Yazaki T., Kajita Y., et al. Detection of human herpesvirus-6 DNAs in samples from several body sites of patients with exanthem-subitum and their mothers by polymerase chain-reaction assay. J Med Virol 1995, 46:52-55.
249. Suga S., Yazaki T., Kajita Y., et al. Detection of human herpesvirus 6 DNAs in samples from several body sites of patients with exanthem subitum and their mothers by polymerase chain reaction assay. J Med Virol 1995, 46:52-55.
250. Suga S., Suzuki K., Ihira M., et al. Clinical characteristics of febrile convulsions during primary HHV-6 infection. Arch Dis Child 2000, 82:62-66.
251. Sugita K., Kurumada H., Eguchi M., et al. Human herpesvirus 6 infection associated with hemophagocytic syndrome. Acta Haematol 1995, 93:108-109.
252. Sutherland S., Christofinis G., O'Grady J., et al. A serological investigation of human herpesvirus 6 infections in liver transplant recipients and the detection of cross-reacting antibodies to cytomegalovirus. J Med Virol 1991, 33:172-176.
253. Tajiri H., Nose O., Baba K., et al. Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet 1990, 335:863.
254. Tajiri H., Tanaka-Taya K., Ozaki Y., et al. Chronic hepatitis in an infant, in association with human herpesvirus-6 infection. J Pediatr 1997, 131:473-475.
255. Takagi M., Unno A., Maruyama T., et al. Human herpesvirus-6 (HHV-6)-associated hemophagocytic syndrome. Pediatr Hematol Oncol 1996, 13:451-456.
256. Takahashi K., Sonoda S., Higashi K., et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 1989, 63:3161-3163.
257. Takikawa T., Hayashibara H., Harada Y., et al. Liver dysfunction, anaemia, and granulocytopenia after exanthema subitum. Lancet 1992, 340:1288-1289.
258. Tejada-Simon M.V., Zang Y.C., Hong J., et al. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003, 53:189-197.
259. Theodore W.H., Bhatia S., Hatta J., et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology 1999, 52:132-136.
260. Theodore W.H., Epstein L., Gaillard W.D., et al. Human herpes virus 6B: A possible role in epilepsy?. Epilepsia 2008, 49:1828-1837.
261. Tiacci E., Luppi M., Barozzi P., et al. Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor. Haematologica 2000, 85:94-97.
262. Tokimasa S., Hara J., Osugi Y., et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002, 29:595-598.
263. Tomoiu A., Flamand L. Biological and clinical advances in human herpesvirus-6 and-7 research. Future Virol 2006, 1:623-635.
264. Tran-Thanh D., Koushik A., Provencher D., et al. Detection of human herpes virus type 6 DNA in precancerous lesions of the uterine cervix. J Med Virol 2002, 68:606-610.
265. Troy S.B., Blackburn B.G., Yeom K., et al. Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. Clin Infect Dis 2008, 47:e93-e96.
266. Uesugi H., Shimizu H., Maehara T., et al. Presence of human herpesvirus 6 and herpes simplex virus detected by polymerase chain reaction in surgical tissue from temporal lobe epileptic patients. Psychiatry Clin Neurosci 2000, 54:589-593.
267. Valente G., Secchiero P., Lusso P., et al. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization. Am J Pathol 1996, 149:1501-1510.
268. Van den Bosch G., Locatelli G., Geerts L., et al. Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection. J Clin Microbiol 2001, 39:2308-2310.
269. VanLandingham K.E., Heinz E.R., Cavazos J.E., et al. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998, 43:413-426.
270. Villoslada P., Juste C., Tintore M., et al. The immune response against herpesvirus is more prominent in the early stages of MS. Neurology 2003, 60:1944-1948.
271. Vinnard C., Barton T., Jerud E., et al. A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl 2009, 15:1242-1246.
272. Virtanen J.O., Farkkila M., Multanen J., et al. Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications. J Neurovirol 2007, 13:347-352.
273. Virtanen J.O., Herrgard E., Valmari R., et al. Confirmed primary HHV-6 infection in children with suspected encephalitis. Neuropediatrics 2007, 38:292-297.
274. Virtanen J.O., Uotila L., Farkkila M., et al. Human herpesvirus 6 antibodies in multiple sclerosis. J Neurovirol 2009, 15:101.
275. Volpi A. Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system. Herpes 2004, 11(Suppl 2):120A-127A.
276. Voumvourakis K.I., Kitsos D.K., Tsiodras S., et al. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin Proc 2010, 85:1023-1030.
277. Wagstaff A.J., Bryson H.M. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Drugs 1994, 48:199-226.
278. Wainwright M.S., Martin P.L., Morse R.P., et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001, 50:612-619.
279. Wang F.Z., Dahl H., Ljungman P., et al. Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults. J Med Virol 1999, 57:134-139.
280. Wang F.Z., Linde A., Dahl H., et al. Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant 1999, 24:1201-1206.
281. Wang F.Z., Linde A., Hagglund A., et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: Does it wave clinical significance?. Clin Infect Dis 1999, 28:562-568.
282. Wang L.R., Dong L.J., Lu D.P. Surveillance of active human herpesvirus 6 infection in chinese patients after hematopoietic stem cell transplantation with 3 different methods. Int J Hematol 2006, 84:262-267.
283. Ward K.N., Gray J.J., Efstathiou S. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989, 28:69-72.
284. Ward K.N., Gray J.J., Fotheringham M.W., et al. IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. J Med Virol 1993, 39:131-138.
285. Ward K.N., Andrews N.J., Verity C.M., et al. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 2005, 90:619-623.
286. Ward K.N., Leong H.N., Nacheva E.P., et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 2006, 44:1571-1574.
287. Ward K.N., Leong H.N., Thiruchelvam A.D., et al. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 2007, 45:1298-1304.
288. Williams-Aziz S.L., Hartline C.B., Harden E.A., et al. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. Antimicrob Agents Chemother 2005, 49:3724-3733.
289. Xiong X., Smith J.L., Kim C., et al. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem Pharmacol 1996, 51:1563-1567.
290. Xu Y., Linde A., Fredrikson S., et al. HHV-6 A- or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum. J Med Virol 2002, 66:394-399.
291. Yadav M., Arivananthan M., Chandrashekran A., et al. Human herpesvirus-6 (HHV-6) DNA and virus-encoded antigen in oral lesions. J Oral Pathol Med 1997, 26:393-401.
292. Yalcin S., Mukai T., Kondo K., et al. Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. J Gen Virol 1992, 73:1673-1677.
293. Yamane A., Mori T., Suzuki S., et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007, 13:100-106.
294. Yamanishi K., Okuno T., Shiraki K., et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988, 1:1065-1067.
295. Yanagihara K., Tanaka-Taya K., Itagaki Y., et al. Human herpesvirus 6 meningoencephalitis with sequelae. Pediatr Infect Dis J 1995, 14:240-242.
296. Yao K., Gagnon S., Akhyani N., et al. Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. PLoS One 2008, 3:e2028.
297. Yao K., Hoest C., Stuve O., et al. Reactivation of human herpesvirus after Natalizumab treatment in patients with multiple sclerosis. J Neurovirol 2009, 15:107.
298. Yao K., Crawford J.R., Komaroff A.L., et al. Review part 2: Human herpesvirus-6 in central nervous system diseases. J Med Virol 2010, 82:1669-1678.
299. Yasukawa M., Inoue Y., Ohminami H., et al. Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection. J Gen Virol 1998, 79:143-147.
300. Yoshida M., Yamada M., Tsukazaki T., et al. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res 1998, 40:73-84.
301. Yoshida H., Matsunaga K., Ueda T., et al. Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int J Hematol 2002, 75:421-425.
302. Yoshikawa T., Asano Y. Central nervous system complications in human herpesvirus-6 infection. Brain Dev 2000, 22:307-314.
303. Yoshikawa T., Nakashima T., Suga S., et al. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics 1992, 89:888-890.
304. Yoshikawa T., Morooka M., Suga S., et al. Five cases of thrombocytopenia induced by primary human herpesvirus 6 infection. Acta Paediatr Jpn 1998, 40:278-281.
305. Yoshikawa T., Ihira M., Suzuki K., et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol 2001, 54:792-795.
306. Yoshikawa T., Asano Y., Ihira M., et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002, 185:847-853.
307. Yoshikawa T., Akimoto S., Nishimura N., et al. Evaluation of active human herpesvirus 6 infection by reverse transcription-PCR. J Med Virol 2003, 70:267-272.
308. Yoshikawa T., Ohashi M., Miyake F., et al. Exanthem subitum-associated encephalitis: nationwide survey in Japan. Pediatr Neurol 2009, 41:353-358.
309. Yoshinari S., Hamano S., Minamitani M., et al. Human herpesvirus 6 encephalopathy predominantly affecting the frontal lobes. Pediatr Neurol 2007, 36:13-16.
310. Zerr D.M. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006, 37(Suppl 1):S52-S56.
311. Zerr D.M. Human herpesvirus 6: a clinical update. Herpes 2006, 13:20-24.
312. Zerr D.M., Gooley T.A., Yeung L., et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001, 33:763-771.
313. Zerr D.M., Gupta D., Huang M.L., et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:309-317.
314. Zerr D.M., Yeung L.C., Obrigewitch R.M., et al. Case report: primary human herpesvirus-6 associated with an afebrile seizure in a 3-week-old infant. J Med Virol 2002, 66:384-387.
315. Zerr D.M., Corey L., Kim H.W., et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:932-940.
316. Zerr D.M., Meier A.S., Selke S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005, 352:768-776.
317. Zerr D.M., Fann J.R., Breiger D., et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011, 117:5243-5249.